Morphine

Clinical Trials

View More Clinical Trials

Sign in to access the complete clinical trial database with detailed study information.

Title	Posted	Study ID	Phase	Status	Sponsor
A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery	2024/11/08	NCT06680466	Phase 2	Active, not recruiting	Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
Analgesic Effect of Bilateral Subcostal Quadratus Lumborum Block in Laparoscopic Colorectal Surgery	2024/10/22	NCT06653439	Not Applicable	Completed	Ondokuz Mayıs University
Effect of Unilateral Erector Spinae Plane Block Versus Intrathecal Morphine on Early Mobilization After Hip Replacement	2024/10/01	NCT06621849	Early Phase 1	Recruiting	Cairo University
Quality of Labour Epidural Analgesia With Intrathecal Morphine as a Component of Combined Spinal Epidural: a Double-blinded Randomized Control Trial	2024/08/27	NCT06572241	Not Applicable	Recruiting	Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Analgesic Efficacy of Intrathecal Fentanyl-Morphine Combination Versus Morphine Alone for Intraoperative Pain During Elective Cesarean Delivery	2024/08/26	NCT06570343	Phase 4	Not yet recruiting	Seoul National University Hospital
Effectiveness of Ultrasound-Guided Erector Spinae Plane Block for Postoperative Pain Control in Open Knee Surgeries	2024/08/20	NCT06562634	Not Applicable	ENROLLING_BY_INVITATION	Cairo University
Compare the Efficacy and Outcome Between Fentanyl and Morphine as Analgo-sedation in Mechanically Ventilated Patients	2024/06/28	NCT06479655	Phase 4	Not yet recruiting	Universiti Sains Malaysia
Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic Surgery	2024/06/21	NCT06467409	Phase 2	Recruiting	Luye Pharma Group Ltd.
Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine Vs Oral Morphine	2024/06/18	NCT06464146	Phase 3	Recruiting	Assistance Publique - Hôpitaux de Paris
To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain	2024/06/13	NCT06458400	Phase 4	Completed	Yuwei Qiu

FDA Drug Approvals

View More FDA Approvals

Sign in to access additional FDA-approved drug information with detailed regulatory data.

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Morphine Sulfate	Bryant Ranch Prepack	63629-2302	ORAL	20 mg in 1 mL	1/6/2022
Morphine sulfate	Sun Pharmaceutical Industries, Inc.	63304-451	ORAL	30 mg in 1 1	12/14/2023
Morphine Sulfate	Fresenius Kabi USA, LLC	76045-005	INTRAVENOUS, INTRAMUSCULAR	4 mg in 1 mL	8/31/2020
MITIGO	Piramal Critical Care, Inc.	66794-162	EPIDURAL, INTRATHECAL	500 mg in 20 mL	7/23/2025
Morphine Sulfate	Par Pharmaceutical Inc.	49884-670	ORAL	100 mg in 1 1	2/19/2015
Morphine Sulfate	Precision Dose, Inc.	68094-256	ORAL	100 mg in 5 mL	6/30/2023
Morphine Sulfate Extended Release	Rhodes Pharmaceuticals L. P.	42858-802	ORAL	30 mg in 1 1	12/31/2023
Morphine Sulfate	Physicians Total Care, Inc.	54868-5590	ORAL	100 mg in 1 1	3/7/2011
MS Contin	Purdue Pharma LP	59011-262	ORAL	60 mg in 1 1	3/23/2017
Morphine Sulfate	Hospira, Inc.	0409-1134	INTRAVENOUS	50 mg in 1 mL	10/13/2021

EMA Drug Approvals

View More EMA Approvals

Sign in to access additional EMA-approved drug information with detailed regulatory data.

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Sign in to access additional HSA-approved drug information with detailed regulatory data.

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Sign in to access additional NMPA-approved drug information with detailed regulatory data.

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Sign in to access additional PPB-approved drug information with detailed regulatory data.

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Sign in to access additional TGA-approved drug information with detailed regulatory data.

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
MS CONTIN morphine sulfate pentahydrate	43086	Mundipharma Pty Ltd	Medicine	A	7/21/1993
MORPHINE SULFATE 10 mg/1 mL MEDICIANZ morphine sulfate pentahydrate 10 mg/1 mL solution for injection ampoule	308720	Medsurge Pharma Pty Ltd	Medicine	A	7/9/2019
DBL MORPHINE SULFATE 15mg/1mL injection ampoule	101243	Pfizer Australia Pty Ltd	Medicine	A	7/21/2004
MORPHINE SULFATE 30 mg/1 mL MEDICIANZ morphine sulfate pentahydrate 30 mg/1 mL solution for injection ampoule	308719	Medsurge Pharma Pty Ltd	Medicine	A	7/9/2019
KAPANOL morphine sulfate pentahydrate 50 mg capsule blister pack	48135	Mayne Pharma International Pty Ltd	Medicine	A	7/21/1994
ARX MORPHINE MR morphine sulfate pentahydrate 10 mg modified release tablet blister packs	132251	Southern Cross Pharma Pty Ltd	Medicine	A	4/22/2009
ARX MORPHINE MR morphine sulfate pentahydrate 100 mg modified release tablet blister packs	132258	Southern Cross Pharma Pty Ltd	Medicine	A	4/22/2009
KADIAN morphine sulfate pentahydrate 100mg sustained release capsule bottle	56833	Mayne Pharma International Pty Ltd	Medicine	A	8/13/1996
MS CONTIN 10mg	210776	Mundipharma Pty Ltd	Medicine	A	6/24/2013
MORPHINE SULFATE 2 mg/1 mL MEDSURGE morphine sulfate pentahydrate 2 mg/1 mL solution for injection ampoule	308716	Medsurge Pharma Pty Ltd	Medicine	A	7/9/2019

Health Canada Drug Approvals

View More Health Canada Approvals

Sign in to access additional Health Canada approved drug information with detailed regulatory data.

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
M.O.S. SYRUP 1.0 MG/ML	valeant canada lp / valeant canada s.e.c.	00486582	Syrup - Oral	1 MG / ML	12/31/1980
M.O.S.-50 CONCENTRATE LIQ 50MG/ML	valeant canada lp / valeant canada s.e.c.	00690236	Syrup - Oral	50 MG / ML	12/31/1986
M.O.S. 20 CONCENTRATE 20MG/ML	valeant canada lp / valeant canada s.e.c.	00632481	Syrup - Oral	20 MG / ML	12/31/1985
M-EDIAT	Ethypharm Inc	02320436	Capsule (Immediate Release) - Oral	20 MG	9/6/2016
MS CONTIN	purdue pharma	02014327	Tablet (Extended-Release) - Oral	200 MG	12/31/1993
MORPHINE SULFATE INJECTION SDZ	Sandoz Canada, Inc.	02382970	Solution - Intramuscular , Intravenous , Subcutaneous	1 MG / ML	N/A
MS CONTIN	purdue pharma	02015439	Tablet (Extended-Release) - Oral	15 MG	12/31/1993
NTP-MORPHINE SR	teva canada limited	02346370	Tablet (Extended-Release) - Oral	30 MG	N/A
MORPHINE SULPHATE INJECTION 2MG/ML	hospira healthcare ulc	02137240	Liquid - Subcutaneous , Intravenous	2 MG / ML	9/4/1997
TEVA-MORPHINE SR	teva canada limited	02302780	Tablet (Extended-Release) - Oral	60 MG	4/1/2008

CIMA AEMPS Drug Approvals

View More CIMA AEMPS Approvals

Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

View More Philippines FDA Approvals

Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

View More Saudi SFDA Approvals

Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

View More Malaysia NPRA Approvals

Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

View More UK EMC Drug Information

Sign in to access additional UK EMC drug information with detailed pharmaceutical data.

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

No news found

AI-Powered Research

Premium Access

Overview

Indication

Associated Conditions